key: cord-0917155-np62dnqk
authors: AlShamrani, N. H.
title: Stability of an HTLV-HIV coinfection model with multiple delays and CTL-mediated immunity
date: 2021-05-25
journal: Adv Differ Equ
DOI: 10.1186/s13662-021-03416-7
sha: 0d1d40c6363a62a41cdba9577e90d9266ba78259
doc_id: 917155
cord_uid: np62dnqk

In the literature, several mathematical models have been formulated and developed to describe the within-host dynamics of either human immunodeficiency virus (HIV) or human T-lymphotropic virus type I (HTLV-I) monoinfections. In this paper, we formulate and analyze a novel within-host dynamics model of HTLV-HIV coinfection taking into consideration the response of cytotoxic T lymphocytes (CTLs). The uninfected [Formula: see text] cells can be infected via HIV by two mechanisms, free-to-cell and infected-to-cell. On the other hand, the HTLV-I has two modes for transmission, (i) horizontal, via direct infected-to-cell touch, and (ii) vertical, by mitotic division of active HTLV-infected cells. It is well known that the intracellular time delays play an important role in within-host virus dynamics. In this work, we consider six types of distributed-time delays. We investigate the fundamental properties of solutions. Then, we calculate the steady states of the model in terms of threshold parameters. Moreover, we study the global stability of the steady states by using the Lyapunov method. We conduct numerical simulations to illustrate and support our theoretical results. In addition, we discuss the effect of multiple time delays on stability of the steady states of the system.

During the past several decades many human viruses and their associated diseases, such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV), dengue virus, human T-lymphotropic virus type I (HTLV-I), and recently coronavirus, have been recognized. Human body can be infected by more that one virus at the same time such as HTLV-HIV, coronavirus/influenza, HCV-HIV, HBV-HIV, HCV-HBV, and malaria-HIV. HTLV and HIV are universal public health matters. HTLV and HIV are two viruses which infect most effective immune cells, CD4 + T cells. Adult T-cell leukemia (ATL) and HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) are the last stage of HTLV-I infection. Chronic HIV infection leads to acquired immunodefi-ciency syndrome (AIDS). Both HTLV and HIV have the same ways of transmission such as sharing contaminated needles and unprotected sexual contact with infected partners. Over the last 10 years HTLV-HIV coinfection has been widely documented (see e.g. [1] [2] [3] , and [4] ).

Mathematical models of HIV and HTLV-I dynamics have become efficient tools to biological and medical scientists. These models can provide a deeper understanding of withinhost virus dynamics and assist in predicting the impact of antiviral drug efficacy on viral infection progression (see e.g. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] ).

• HIV monoinfection model: The standard HIV dynamics model under the effect of cytotoxic T lymphocytes (CTLs) has been formulated by Nowak and Bangham [17] as follows:

where S(t), I(t), V (t), and C I (t) are the concentrations of uninfected CD4 + T cells, active HIV-infected cells, free HIV particles, and HIV-specific CTLs, respectively, and t is the time. η refers to the generation rate of the uninfected CD4 + T cells. The uninfected CD4 + T cells are infected via HIV particles (free-to-cell infection) at rate ϑ 1 SV . The HIV-infected cells produce HIV particles at rate bI. The stimulation rate of effective HIV-specific CTLs due to the presence of HIV-infected cells is defined by σ 1 C I I. The term μ 1 C I I accounts for the killing rate of HIV-infected cells due to its specific CTLs. The four compartments S, I, V , and C I have normal death rates S, aI, εV , and π 1 C I , respectively. Several extensions on model (1) have been accomplished (see e.g. [18] [19] [20] ). • HTLV-I monoinfection model: The within-host dynamics of HTLV-I has been mathematically modeled in several papers [21] [22] [23] [24] . CTL immunity has been included into the HTLV-I dynamics models in many works (see e.g. [25] [26] [27] [28] [29] [30] [31] [32] [33] ). Lim and Maini [28] have formulated a model for HTLV-I dynamics under the consideration of CTL immunity and mitotic division of active HTLV-infected cells as follows:

where E(t), Y (t), and C Y (t) are the concentrations of latent HTLV-infected cells, active HTLV-infected cells, and HTLV-specific CTLs at time t, respectively. The term ϑ 3 SY denotes the infected-to-cell contact rate between HTLV-infected cells and uninfected CD4 + T cells (horizontal transmission). The active HTLV-infected cells transmit vertically to latent compartment at rate Kr * Y (mitotic transmission), where K ∈ (0, 1). The HTLV-specific CTLs kill the active HTLV-infected cells at rate μ 2 C Y Y and are stimulated at rate σ 2 Y . The term ψE denotes the activation rate of latent HTLV-infected cells. The death rates of E, Y , and C Y are given by ωE, δ * Y , and π 2 C Y , respectively.

• HTLV-HIV coinfection model: Elaiw and AlShamrani [34] have recently formulated an HTLV-HIV coinfection model as follows:

where L(t) is the concentration of latent HIV-infected cells. The term ϑ 2 SI describes the infection rate of uninfected CD4 + T cells by HIV-infected cells. λL and γ L are the activation and death rates of latent HIV-infected cells. The parameter β ∈ (0, 1)

represents the part of newly HIV-infected cells that becomes active, and the other part 1β enters a latent stage. The parameter ϕ ∈ (0, 1) refers to the part of newly HTLV-infected cells that become latent.

Intracellular delay plays a crucial role in within-host virus dynamics and is defined as the time lapse between viral entry a cell and its production. In case of HIV, it has been estimated that the time between the HIV enters a target cell until producing new HIV particles is about 0.9 days [35] . Time delay has also an important effect in HTLV-I infection. Several works have been devoted to developing mathematical models with time delays to describe the dynamics of HIV (see e.g. [36] [37] [38] [39] [40] [41] [42] [43] ) and HTLV (see e.g. [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] ).

Our aim is to take model (3) to further destination by incorporating multiple intracellular time delays and mitotic transmission. We study the fundamental and global properties of the system, then we present numerical simulation. The outcomes of this paper will help clinicians to estimate the suitable time to start the treatment. Our model may be helpful to study different coinfections such as influenza-coronavirus, HCV-HIV, HBV-HIV, and malaria-HIV. It is interesting to note that fractional-order differential equations (FODEs) have been widely studied in several works (see e.g. [54] [55] [56] [57] ). Modeling and analysis of HIV dynamics with FODEs have been investigated in many papers (see e.g. [58] [59] [60] ). Clinicians can use the information (in terms of behavior predictions) of fractional-order systems to fit patients' data with the most appropriate nonintegerorder index. As a future work, our coinfection model can be formulated as a system of FODEs.

In this section, we extend system (3) by taking under consideration multiple types of distributed-time delays and mitosis of active HTLV-infected cells. We achieve this goal by considering the following system of delay differential equations (DDEs):

The factor 1 ( )e -1 represents the probability that uninfected CD4 + T cells contacted by HIV particles or active HIV-infected cells at time t -survived time units and become latent infected at time t. The term 2 ( )e -2 is the probability that uninfected CD4 + T cells contacted by HIV particles or active HIV-infected cells at time t -survived time units and become actively infected at time t. The term 3 ( )e -3 is the probability that latent HIV-infected CD4 + T cells survived time units before transmitted to be active at time t. Moreover, the factor 4 ( )e -4 demonstrates the probability that the initial infection of uninfected CD4 + T cells and the HTLV-infected cells at time t -completing all the intracellular processes that are required for it to become latent HTLV-infected CD4 + T cells at time t. Further, the probability that latent HTLV-infected CD4 + T cells survived time units before transmitted to active HTLV-infected cells at time t is given by the factor 5 ( )e -5 . Furthermore, the term 6 ( )e -6 refers to the probability that new immature HIV particles at time t -lost time units and become mature at time t. Here i , i = 1, 2, . . . , 6, are positive constants. The delay parameter is randomly taken from a probability distribution function i ( ) over the time interval [0, κ i ], i = 1, 2, . . . , 6, where κ i is the limit superior of this delay period. The function i ( ), i = 1, 2, . . . , 6 satisfies i ( ) > 0

where u > 0. Let us denotē

where i = 1, 2, . . . , 6. Thus 0 < H i ≤ 1, i = 1, 2, . . . 6.

According to [28] , we assume that r * < min{ , ω, δ * }. This yields δ * -(1 -K)r * > 0. Let r = Kr * and δ = δ * -(1 -K)r * . Then system (4) becomes

The initial conditions of system (5) are given by:

is the Banach space of continuous functions mapping the interval [-κ, 0] into R ≥0 with norm j = sup -κ≤q≤0 | j (q)| for j ∈ C. Therefore, system (5) with initial conditions (6) has a unique solution by using the standard theory of functional differential equations [61, 62] .

C I (t) = 7 (0)e -t 0 (π 1 -σ 1 I(y)) dy ,

Thus, by a recursive argument, we get S(t), L(t),

Hence, the solutions of system (5) with initial conditions (6) satisfy (S(t), L(t),

≥0 for all t ≥ 0. Next, we establish the boundedness of the model's solutions. The nonnegativity of the model's solution implies that lim sup t→∞ S(t) ≤ η . To show the ultimate boundedness of L(t), we let

Then

where φ 1 = min{ , λ + γ }. It follows that lim sup t→∞ 1 (t) ≤ 1 , where 1 = η(1-β) φ 1 . Since κ 1 0H 1 ( )S(t -) d and L(t) are nonnegative, then lim sup t→∞ L(t) ≤ 1 . Further, we let

Then we obtain

where φ 2 = min{ , a, π 1 }. It follows that lim sup t→∞ 2 (t) ≤ 2 , where 2 = ηβ+λ 1 φ 2 . Since κ 2 0H 2 ( )S(t -) d , I(t) and C I (t) are nonnegative, then lim sup t→∞ I(t) ≤ 2 and lim sup t→∞ C I (t) ≤ 3 , where 3 = σ 1 2 μ 1 . Furthermore, we let

Then

Since δr = δ *r * > 0, then

where φ 3 = min{ , ω, δ *r * , 5 , π 2 }. It follows that lim sup t→∞ 3 (t) ≤ η φ 3 . Since

and C Y (t) ≥ 0, then lim sup t→∞ E(t) ≤ 4 , lim sup t→∞ Y (t) ≤ 4 , and lim sup t→∞ C Y (t) ≤ 5 , where 4 = ηϕ φ 3 and 5 = ησ 2 ϕ μ 2 φ 3 . Finally, from the sixth equation of system (5), we have

This implies that lim sup t→∞ V (t) ≤ 6 , where 6 

According to Proposition 1, we can show that the region

is positively invariant with respect to system (5).

In this section, we calculate all possible steady states of the model and derive the threshold parameters which guarantee the existence of the steady states. Let us define

which will be used throughout the paper. Let (S, L, I, E, Y , V , C I , C Y ) be any steady state of system (5) satisfying the following equations:

We find that system (5) has eight possible steady states.

(i) Infection-free steady state, Ð 0 = (S 0 , 0, 0, 0, 0, 0, 0, 0), where S 0 = η/ . In this case, the body is free from HTLV and HIV.

(ii) Persistent HIV monoinfection steady state with ineffective immune response, Ð 1 = (S 1 , L 1 , I 1 , 0, 0, V 1 , 0, 0), where

( 1 -1),

and 1 is the basic HIV monoinfection reproduction number for system (5) and is defined as follows:

The parameter 1 determines whether or not a persistent HIV infection can be established. In fact, 11 measures the average number of secondary HIV infected generation caused by an existing free HIV particle due to free-to-cell transmission, while 12 measures the average numbers of secondary HIV infected generation caused by living active HIV-infected cells due to infected-to-cell transmission. The steady state Ð 1 describes the case of persistent HIV monoinfection without immune response.

(iii) Persistent HTLV monoinfection steady state with ineffective immune response,

and 2 is the basic HTLV monoinfection reproduction number for system (5) and is defined as follows:

The parameter 2 decides whether or not a persistent HTLV infection can be established. The steady state Ð 2 describes a persistent HTLV monoinfection without immune response.

We mention that 1 and 2 state the threshold dynamics of infection-free equilibrium Ð 0 and can be calculated by different methods such as (a) the next-generation matrix method of van den Driessche and Watmough [63], (b) local stability of the infection-free equilibrium Ð 0 , and (c) the existence of the chronic HIV and HTLV monoinfection equilibria with inactive immune response. In the present paper, we derive 1 and 2 by method (c).

(iv) Persistent HIV monoinfection steady state with only effective HIV-specific CTL, Ð 3 = (S 3 , L 3 , I 3 , 0, 0, V 3 , C I 3 , 0), where S 3 = εσ 1 η π 1 (bϑ 1 H 6 + εϑ 2 ) + εσ 1 ,

,

is the HIV-specific CTL immunity reproduction number in case of HIV monoinfection. The parameter 3 determines whether or not the HIV-specific CTL immune response is effective in the absence of HTLV.

(v) Persistent HTLV monoinfection steady state with only effective HTLV-specific CTL,

and 4 is the HTLV-specific CTL immunity reproduction number in case of HTLV monoinfection and is stated as follows:

The parameter 4 determines whether or not the HTLV-specific CTL immune response is effective in the absence of HIV.

(vi) Persistent HTLV-HIV coinfection steady state with only effective HIV-specific CTL, Ð 5 = (S 5 , L 5 , I 5 , E 5 , Y 5 , V 5 , C I 5 , 0), where S 5 = (δ -rH 5 )ψ + δω ϕϑ 3 ψH 4 H 5 = S 2 , Here, the parameter 5 is the HTLV infection reproduction number in the presence of HIV infection and determines whether or not HIV-infected patients could be dually infected with HTLV.

(vii) Persistent HTLV-HIV coinfection steady state with only effective HTLV-specific CTL, Ð 6 = (S 6 , L 6 , I 6 , E 6 , Y 6 , V 6 , 0, C Y 6 ), where

is the HIV infection reproduction number in the presence of HTLV infection. It is clear that 6 determines whether or not HTLV-infected patients could be dually infected with HIV.

(viii) Persistent HTLV-HIV coinfection steady state with effective HIV-specific CTL and HTLV-specific CTL, Ð 7 = (S 7 , L 7 , I 7 , E 7 , Y 7 , V 7 , C I 7 , C Y 7 ), where S 7 = εσ 1 σ 2 η π 1 σ 2 (bϑ 1 H 6 + εϑ 2 ) + εσ 1 (π 2 ϑ 3 + σ 2 ) ,

The parameter 7 is the competed HIV-specific CTL immunity reproduction number in case of HTLV-HIV coinfection. The parameter 8 is the competed HTLV-specific CTL immunity reproduction number in case of HTLV-HIV coinfection. Clearly, Ð 7 exists when 7 > 1 and 8 > 1.

In this section, we use the Lyapunov method to show the global asymptotic stability of the model's steady states. For formation of Lyapunov functionals, we follow the works [64, 65] .

We define a function (x) = x -1 -ln x.

Theorem 1 If 1 ≤ 1 and 2 ≤ 1, then Ð 0 is globally asymptotically stable (GAS).

Proof We define a Lyapunov functional as follows:

Clearly, 0 (S, L, I, E, Y , V , C I , C Y ) > 0 for all S, L, I, E, Y , V , C I , C Y > 0, and 0 (S 0 , 0, 0, 0, 0, 0, 0, 0) = 0. We calculate d 0 dt along the solutions of model (5) as follows:

Summing the terms of Eq. (9), we obtain

Using S 0 = η/ , we obtain

Since r < δ and 0 < H 5 ≤ 1, then δ -rH 5 > 0. Therefore

dt = 0 and the first and fifth equations of system (5) become

In addition, we have dI(t) dt = 0, and from the third equation of system (5) we have

which yields L(t) = 0 for all t and hence ϒ 0 = {Ð 0 }. Applying Lyapunov-LaSalle asymptotic stability (LLAS) theorem [66] [67] [68] , we get that Ð 0 is GAS.

The following equalities are needed in the next theorems:

Further,

Theorem 2 Let 1 > 1, 2 / 1 ≤ 1, and 3 ≤ 1, then Ð 1 is GAS.

Proof Define a functional as follows:

Calculate d 1 dt as follows:

Summing the terms of Eq. (12), we get

The steady state conditions for Ð 1 are given by

Then we get

Further, we obtain

Using the equalities given by (10) in case of n = 1, we get

Therefore, Eq. (13) becomes

Since 2 / 1 ≤ 1 and 3 ≤ 1, then d 1 dt ≤ 0 for all S, L, I, Y , V , C I , C Y > 0. Moreover, d 1 dt = 0 when S = S 1 and Y = C I = C Y = = 0. The solutions of system (5) converge to ϒ 1 which includes elements that satisfy S(t) = S 1 and = 0 i.e.

for all t ∈ [0, κ]. If S(t) = S 1 , then from Eq. (14) we get L(t) = L 1 , I(t) = I 1 , and V (t) = V 1 for all t. Further, for each element of ϒ 1 , we have Y (t) = 0 and then dY (t) dt = 0. The fifth equation of system (5) becomes

which provides E(t) = 0 for all t, and hence ϒ 1 = {Ð 1 }. Therefore, using LLAS theorem we get that Ð 1 is GAS.

We calculate d 2 dt as follows:

By collecting the terms of Eq. (15), we get

Using the steady state conditions for Ð 2

we obtain

Using the equalities given by (11) in case of m = 2, we get

Therefore, Eq. (16) becomes 

which yields V (t) = 0 for all t. Moreover, we have dI(t) dt = 0 and from the third equation of system (5) we get

which implies that L(t) = 0 for all t. Therefore, ϒ 2 = {Ð 2 }. Applying LLAS theorem, we get Ð 2 is GAS.

Theorem 4 Let 3 > 1 and 5 ≤ 1, then Ð 3 is GAS.

Proof Define a functional as follows:

We calculate d 3 dt as follows:

Collecting the terms of Eq. (18), we derive

6 ( ) ln

Using the steady state conditions for Ð 3

we get

Further, we obtain

Using the equalities given by (10) in case of n = 3, we get

Therefore, Eq. (19) becomes

Hence, if 5 ≤ 1, then Ð 5 does not exist since E 5 ≤ 0 and Y 5 ≤ 0. In this case

Now we want to find the valueS such that, for all 0 < S(t) ≤S, we get dE(t) dt ≤ 0 and dY (t) dt ≤ 0. Let us consider d dt

This happens when S 3 ≤S = (δ-rH 5 )ψ+δω 

which yield C I (t) = C I 3 and E(t) = 0 for all t. Therefore, ϒ 3 = {Ð 3 }. Applying LLAS theorem, we get Ð 3 is GAS.

Theorem 5 If 4 > 1 and 6 ≤ 1, then Ð 4 is GAS.

Calculate d 4 dt as follows:

Summing the terms of Eq. (21), we get

Using the steady state conditions for Ð 4

we obtain

Using the equalities given by (11) in case of m = 4, we get

Therefore, Eq. (22) becomes 

which imply that V (t) = 0 and C Y (t) = C Y 4 for all t. Moreover, we have dI(t) dt = 0, then the third equation of system (5) becomes

which yields L(t) = 0 for all t, and then ϒ 4 = {Ð 4 }. Applying LLAS theorem, we get Ð 4 is GAS.

Theorem 6 If 5 > 1, 8 ≤ 1, and 1 / 2 > 1, then Ð 5 is GAS.

Proof Define

Calculate d 5 dt as follows:

Summing the terms of Eq. (23), we get

6 ( )

6 ( ) ln

Using the steady state conditions for Ð 5

we obtain

Moreover, we get

Using the equalities given by (10) and (11) in case of n = m = 5, we get

6 ( )

Therefore, Eq. (24) becomes

6 ( )

Hence, if 8 

which yields C I (t) = C I 5 for all t, and hence ϒ 5 = {Ð 5 }. Applying LLAS theorem, we get Ð 5 is GAS. Theorem 7 If 6 > 1, 7 ≤ 1, and 2 / 1 > 1, then Ð 6 is GAS.

Calculate d 6 dt as follows:

Collecting the terms of Eq. (25), we obtain

6 ( )

6 ( ) ln

Using the steady state conditions for Ð 5 η = S 6 + ϑ 1 S 6 V 6 + ϑ 2 S 6 I 6 + ϑ 3 S 6 Y 6 , H 1 (1β)(ϑ 1 S 6 V 6 + ϑ 2 S 6 I 6 ) = (λ + γ )L 6 , βH 2 (ϑ 1 S 6 V 6 + ϑ 2 S 6 I 6 ) + λH 3 L 6 = aI 6 ,

we get P(ϑ 1 S 6 V 6 + ϑ 2 S 6 I 6 ) = a(λ + γ )I 6 .

Moreover, we get

Using the equalities given by (10) and (11) in case of n = m = 6, we get

Therefore, Eq. (26) becomes

6 ( )

Hence, if 7 ≤ 1, then 

which yields C Y (t) = C Y 6 for all t, and hence ϒ 6 = {Ð 6 }. Applying LLAS theorem, we get Ð 6 is GAS. 

Calculate d 7 dt as follows:

Summing the terms of Eq. (27), we get

6 ( )

6 ( ) ln

Using the steady state conditions for Ð 7 η = S 7 + ϑ 1 S 7 V 7 + ϑ 2 S 7 I 7 + ϑ 3 S 7 Y 7 ,

βH 2 (ϑ 1 S 7 V 7 + ϑ 2 S 7 I 7 ) + λH 3 L 7 = a + μ 1 C I 7 I 7 ,

we get

Moreover, we get

6 ( ) ln

Using the equalities given by (10) and (11) in case of n = m = 7, we get

Therefore, Eq. (28) becomes

Hence, . The solutions of system (5) converge to ϒ 7 which includes elements with (S, L, I, E, Y , V )(t) = (S 7 , L 7 , I 7 , E 7 , Y 7 , V 7 ). Then

The third and fifth equations of system (5) become 0 = dI(t) dt = βH 2 (ϑ 1 S 7 V 7 + ϑ 2 S 7 I 7 ) + λH 3 L 7 -aI 7μ 1 C I (t)I 7 ,

which yield C I (t) = C I 7 and C Y (t) = C Y 7 for all t, and hence ϒ 7 = {Ð 7 }. Applying LLAS theorem, we get Ð 7 is GAS.

In this section, we perform numerical simulations to illustrate the results of Theorems 1-8. Moreover, we study the influence of time delays on the dynamical behavior of the system. Let us choose a Dirac delta function D(·) as a special form of the kernel i (·) as follows:

Let κ i → ∞, then we get ∞ 0 j (ς) dς = 1,

D(ςj )ej ς dς = ej j , j = 1, 2, . . . , 6.

Thus, model (4) reduces to

For model (29) , the threshold parameters are given by 1 =

PS 0 (bϑ 1 e -6 6 + εϑ 2 ) aε(γ + λ) , 2 = ϕϑ 3 ψe -( 4 4 + 5 5 ) S 0 (δre -5 5 )ψ + δω , 3 = σ 1 ηP(bϑ 1 e -6 6 + εϑ 2 ) a(γ + λ)[π 1 (bϑ 1 e -6 6 + εϑ 2 ) + εσ 1 ] , 4 = σ 2 ηϕϑ 3 ψe -( 4 4 + 5 5 ) (π 2 ϑ 3 + σ 2 )[(δre -5 5 )ψ + δω] , 5 = ηϕεϑ 3 σ 1 ψe -( 4 4 + 5 5 ) [(δre -5 5 )ψ + δω][π 1 (bϑ 1 e -6 6 + εϑ 2 ) + εσ 1 ] , 6 = ησ 2 P(bϑ 1 e -6 6 + εϑ 2 ) aε(γ + λ)(π 2 ϑ 3 + σ 2 ) , 7 = σ 1 σ 2 ηP(bϑ 1 e -6 6 + εϑ 2 ) a(γ + λ)[π 1 σ 2 (bϑ 1 e -6 6 + εϑ 2 ) + εσ 1 (π 2 ϑ 3 + σ 2 )] , 8 = εϑ 3 ησ 1 σ 2 ϕψe -( 4 4 + 5 5 ) [π 1 σ 2 (bϑ 1 e -6 6 + εϑ 2 ) + εσ 1 (π 2 ϑ 3 + σ 2 )][(δre - 5 5 

where

To solve system (29) numerically, we fix the values of some parameters (see Table 1 ) and the others will be varied. 

In this subsection, we select the delay parameters as 1 = 1, 2 = 0.8, 3 Choosing different values of ϑ 1 , ϑ 2 , ϑ 3 , ϑ 4 , σ 1 , and σ 2 under the above initial conditions leads to the following sets:

Set 1 (Stability of Ð 0 ): ϑ 1 = 0.0002, ϑ 2 = 0.0001, ϑ 3 = 0.001, σ 1 = 0.3, and σ 2 = 0.5. For this set of parameters, we have 1 = 0.76 < 1 and 2 = 0.27 < 1. Figure 1 illustrates that the trajectories starting different initials converge to the steady state Ð 0 = (1000, 0, 0, 0, 0, 0, 0, 0). This supports the global stability result of Theorem 1. Here, a healthy state will be reached where both viruses are absent. With such a choice we get 2 = 0.19 < 1 < 1.96 = 1 , 3 = 0.34 < 1, and hence 2 / 1 = 0.1 < 1. The steady state Ð 1 exists with Ð 1 = (510.18, 4.01, 6.66, 0, 0, 15.21, 0, 0). The stability of Ð 1 given in Theorem 2 is shown in Fig. 2 . This leads to the case where HIV monoinfection is chronic but with an ineffective CTL immunity.

Set 3 (Stability of Ð 2 ): ϑ 1 = 0.0001, ϑ 2 = 0.0003, ϑ 3 = 0.005, σ 1 = 0.001, and σ 2 = 0.05. Then we calculate 1 = 0.72 < 1 < 1.34 = 2 , 4 = 0.67 < 1, and then 1 / 2 = 0.54 < 1 and Ð 2 = (736.51, 0, 0, 13.23, 0.72, 0, 0, 0). We can see from Fig. 3 that the system's solutions tend to Ð 2 , which is compatible with Theorem 3. This case means that an HTLV monoinfection is chronic with an ineffective CTL immunity.

Set 4 (Stability of Ð 3 ): ϑ 1 = 0.0005, ϑ 2 = 0.0003, ϑ 3 = 0.002, σ 1 = 0.05, and σ 2 = 0.005. Then we calculate 3 = 1.52 > 1 and 5 = 0.42 < 1. Figure 4 shows that the trajectories starting with different states tend to Ð 3 = (776.11, 1.83, 2, 0, 0, 4.57, 1.30, 0). Therefore, Ð 3 is GAS, and this supports Theorem 4. Hence, an HIV monoinfection is chronic with effective HIV-specific CTL immunity. exists and is GAS. This case leads to a chronic coinfection with HTLV and HIV where the HIV-specific CTL immunity is effective while the HTLV-specific CTL immunity is ineffective.

Set 7 (Stability of Ð 6 ): ϑ 1 = 0.0004, ϑ 2 = 0.0002, ϑ 3 = 0.01, σ 1 = 0.007, and σ 2 = 0.7. We compute 6 = 1.32 > 1, 7 = 0.55 < 1, and 2 / 1 = 1.77 > 1. According to these values, we obtain that Ð 6 = (660.63, 2.01, 3.33, 4.71, 0.14, 7.61, 0, 0.19) exists. The numerical solutions of our system plotted in Fig. 7 show that Ð 6 is GAS (Theorem 7). This case leads to a chronic coinfection with HTLV and HIV where the HTLV-specific CTL immunity is effective and the HIV-specific CTL immunity is not working. 

In this part we vary the delay parameters i , i = 1, 2, . . . , 6, and fix the parameters ϑ 1 = 0.0005, ϑ 2 = 0.0003, ϑ 3 = 0.01, σ 1 = 0.04, and σ 2 = 0.7. Since 1 and 2 given by Eqs. (30) and (31) depend on i , i = 1, 2, . . . , 6, then changing the parameters i will change the stability of steady states. Let us consider the following situations:

(D.P.S1) 1 = 2 = 3 = 4 = 5 = 6 = 0, (D.P.S2) 1 = 0.4, 2 = 0.5, 3 = 0.6, 4 = 0.7, 5 = 0.8, and 6 = 0.9, (D.P.S3) 1 = 0.6, 2 = 0.7, 3 = 0.8, 4 = 0.9, 5 = 1, and 6 = 1.2, (D.P.S4) 1 = 10, 2 = 11, 3 = 12, 4 = 13, 5 = 14, and 6 = 15.

Impact of delay parameters i , i = 1, 2, . . . , 6, on the behavior of solution trajectories of system (29) With these values we solve system (29) under the following initial condition: From Fig. 9 we observe that the presence of time delays can increase the number of uninfected CD4 + T cells and decrease the number of other compartments. Table 2 presents the values 1 and 2 for selected values of i , i = 1, 2, . . . , 6. It is clear that 1 and 2 are decreased when i are increased, and thus the stability of Ð 0 can be changed. Let us calculate the critical value of the time delay that changes the stability of Ð 0 . Without loss of generality, we let the parameters = 1 = 2 = 3 and fix j , j = 5, 6, and write 1 and 2 as Table 2 The variation of 1 and 2 with respect to the delay parameters functions of and 4 , respectively, as follows:

[λe -( 1 + 3 ) (1β) + βe -2 (γ + λ)]S 0 (bϑ 1 e -6 6 + εϑ 2 ) aε(γ + λ) ,

Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression

Neurological aspects of HIV/human T lymphotropic virus coinfection

Immune compromise in HIV-1/HTLV-1 coinfection with paradoxical resolution of CD4 lymphocytosis during antiretroviral therapy: a case report

HTLV-1 and HIV-1 co-infection: a case report and review of the literature

Mechanisms of HIV-1 cell-to-cell transmission and the establishment of the latent reservoir

Hopf bifurcation in a CTL-inclusive HIV-1 infection model with two time delays

Global properties of delay-distributed HIV dynamics model including impairment of B-cell functions

Stability of delayed pathogen dynamics models with latency and two routes of infection

Analysis of general humoral immunity HIV dynamics model with HAART and distributed delays

Dynamics of SARS-CoV-2 infection model with two modes of transmission and immune response

Modelling the role of tax expression in HTLV-1 persistence in vivo

Threshold dynamics of a delayed nonlocal reaction-diffusion HIV infection model with both cell-free and cell-to-cell transmissions

Dynamic analysis and optimal control for a model of hepatitis C with treatment

Global properties of an improved hepatitis B virus model

Mathematical modeling and analysis of innate and humoral immune responses to Dengue infections

Virus Dynamics: Mathematical Principles of Immunology and Virology

Population dynamics of immune responses to persistent viruses

Global stability for an HIV-1 infection model with Beddington-DeAngelis incidence rate and CTL immune response

Stability of a general CTL-mediated immunity HIV infection model with silent infected cell-to-cell spread

Dynamical behavior of a virus dynamics model with CTL immune response

Modeling the T-cell dynamics and pathogenesis of HTLV-I infection

Backward bifurcation in a model for HTLV-I infection of CD4 + T cells

The complete classification for global dynamics of a model for the persistence of HTLV-1 infection

Mathematical analysis of the global dynamics of a model for HTLV-I infection and ATL progression

Multi-stability in a model for CTL response to HTLV-I infection and its consequences in HAM/TSP development, and prevention

Stable and transient periodic oscillations in a mathematical model for CTL response to HTLV-I infection

Multiple stable periodic oscillations in a mathematical model of CTL response to HTLV-I infection

HTLV-I infection: a dynamic struggle between viral persistence and host immunity

Backward bifurcation of an HTLV-I model with immune response

Global dynamics of a reaction and diffusion model for an HTLV-I infection with mitotic division of actively infected cells

Persistent virus infection despite chronic cytotoxic T-lymphocyte activation in gamma interferon-deficient mice infected with lymphocytic choriomeningitis virus

Evolutionary dynamics of HTLV-I

The dynamics of HTLV-I and the CTL response

Mathematical modeling of HIV/HTLV-I co-infection with CTL-mediated immunity

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

A model of HIV-1 pathogenesis that includes an intracellular delay

A mathematical model of cell-to-cell spread of HIV-1 that includes a time delay

Effect of cellular reservoirs and delays on the global dynamics of HIV

Stability of delayed HIV dynamics models with two latent reservoirs and immune impairment

Global dynamics of delay-distributed HIV infection models with differential drug efficacy in cocirculating target cells

Dynamical behavior of a delay virus dynamics model with CTL immune response

The effects of CTL immune response on HIV infection model with potent therapy, latently infected cells and cell-to-cell viral transmission

A delay-differential equation model of HIV infection of CD4+ T-cells

Dynamics analysis of an HTLV-1 infection model with mitotic division of actively infected cells and delayed CTL immune response

Rich dynamics in a delayed HTLV-I infection model: stability switch, multiple stable cycles, and torus

Complete dynamical analysis for a nonlinear HTLV-I infection model with distributed delay, CTL response and immune impairment

Viral dynamics of an HTLV-I infection model with intracellular delay and CTL immune response delay

Global dynamics of a mathematical model for HTLV-I infection of CD4+ T cells with delayed CTL response

Global stability of a delayed HTLV-I infection model with a class of nonlinear incidence rates and CTLs immune response

A mathematical model of HTLV-I infection with two time delays

Stability properties and Hopf bifurcation of a delayed viral infection model with lytic immune response

Global stability for delay-dependent HTLV-I model with CTL immune response

Complex dynamic behavior in a viral model with delayed immune response. Phys. D: Nonlinear Phenom

Can transfer function and Bode diagram be obtained from Sumudu transform

Modelling and analysis of fractal-fractional partial differential equations: application to reaction-diffusion model

A novel method for a fractional derivative with non-local and non-singular kernel

Analysis of fractal fractional differential equations

A fractional-order differential equation model of HIV infection of CD4 + T-cells

A fractional-order model of HIV infection with drug therapy effect

Stability analysis of the HIV model through incommensurate fractional-order nonlinear system

Introduction to Functional Differential Equations

Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission

Global properties of basic virus dynamics models

Global properties of a class of HIV models

Introduction to the Theory of Stability

The Stability of Dynamical Systems

The General Problem of the Stability of Motion

ϕϑ 3 ψe -( 4 4 + 5 5 ) S 0 (δre -5 5 )ψ + δω .To force the threshold parameters 1 and 2 to satisfy 1 ( ) ≤ 1 and 2 ( 4 ) ≤ 1, we choose ≥ min , where min is the solution of Therefore, if ≥ min and 4 ≥ min 4 , then Ð 0 is GAS. Let us choose the value 5 = 0.2 and 6 = 0.1 and compute min , min 4 as min = 2.73728, min 4 = 2.36794. It follows that: (i) If ≥ 2.73728 and 4 ≥ 2.36794, then 1 ( ) ≤ 1, 2 ( 4 ) ≤ 1 and Ð 0 is GAS. (ii) If < 2.73728 or 4 < 2.36794, then 1 ( ) > 1 or 2 ( 4 ) > 1 and Ð 0 will lose its stability.

Not applicable.

Not applicable.

The author declares that they have no competing interests.

The author was the only one contributing to the manuscript. The author read and approved the final manuscript.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Received: 15 December 2020 Accepted: 9 May 2021